Wilson Sonsini Goodrich & Rosati advised ONI on the deal. ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its...
ONI’s $75 Million Series B Funding Round
Verana Health’s $150 Million Series E Funding
Wilson Sonsini Goodrich & Rosati advised Verana Health on the deal. Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights...
WuXi AppTec’s Acquisition of OXGENE
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised WuXi AppTec on the deal. WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in...
BlackLine’s Acquisition Of Rimilia Holdings
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised BlackLine, Inc. on the deal. Goodwin Procter LLP advised Rimilia on the deal. BlackLine, Inc., a leader...